{"id":"https://openalex.org/W4401919503","doi":"https://doi.org/10.1192/j.eurpsy.2024.1111","title":"The preponderance of major depressive disorder among women of reproductive age and the clinical utility of sertraline","display_name":"The preponderance of major depressive disorder among women of reproductive age and the clinical utility of sertraline","publication_year":2024,"publication_date":"2024-04-01","ids":{"openalex":"https://openalex.org/W4401919503","doi":"https://doi.org/10.1192/j.eurpsy.2024.1111","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/11863073"},"language":"en","primary_location":{"id":"doi:10.1192/j.eurpsy.2024.1111","doi":"https://doi.org/10.1192/j.eurpsy.2024.1111","is_oa":true,"landing_page_url":"https://doi.org/10.1192/j.eurpsy.2024.1111","pdf_url":"https://www.cambridge.org/core/services/aop-cambridge-core/content/view/841DDB24C4B809AC1ECE8192F854D190/S0924933824011118a.pdf/div-class-title-the-preponderance-of-major-depressive-disorder-among-women-of-reproductive-age-and-the-clinical-utility-of-sertraline-div.pdf","source":{"id":"https://openalex.org/S87202501","display_name":"European Psychiatry","issn_l":"0924-9338","issn":["0924-9338","1778-3585"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311721","host_organization_name":"Cambridge University Press","host_organization_lineage":["https://openalex.org/P4310311721","https://openalex.org/P4310311702"],"host_organization_lineage_names":["Cambridge University Press","University of Cambridge"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Psychiatry","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.cambridge.org/core/services/aop-cambridge-core/content/view/841DDB24C4B809AC1ECE8192F854D190/S0924933824011118a.pdf/div-class-title-the-preponderance-of-major-depressive-disorder-among-women-of-reproductive-age-and-the-clinical-utility-of-sertraline-div.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5051003442","display_name":"Andrea M. Fagiolini","orcid":"https://orcid.org/0000-0001-5827-0853","observed_orcids":["https://orcid.org/0000-0001-5827-0853"]},"institutions":[{"id":"https://openalex.org/I102064193","display_name":"University of Siena","ror":"https://ror.org/01tevnk56","country_code":"IT","type":"education","lineage":["https://openalex.org/I102064193"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"A. Fagiolini","raw_affiliation_strings":["1Department of Molecular Medicine, University of Siena School of Medicine, Siena, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Molecular Medicine, University of Siena School of Medicine, Siena, Italy","institution_ids":["https://openalex.org/I102064193"]}]},{"author_position":"middle","author":{"id":null,"display_name":"M. P. Mariano","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210109993","display_name":"University of the East Ramon Magsaysay Memorial Medical Center","ror":"https://ror.org/01rxjzf54","country_code":"PH","type":"healthcare","lineage":["https://openalex.org/I4210109993"]}],"countries":["PH"],"is_corresponding":false,"raw_author_name":"M. P. Mariano","raw_affiliation_strings":["2Department of Psychiatry, University of the East Ramon Magsaysay Memorial Medical Center, Quezon City, Philippines"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Department of Psychiatry, University of the East Ramon Magsaysay Memorial Medical Center, Quezon City, Philippines","institution_ids":["https://openalex.org/I4210109993"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018168237","display_name":"Egbert Biesheuvel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387153459","display_name":"Viatris","ror":"https://ror.org/01g1gvr46","country_code":"US","type":"company","lineage":["https://openalex.org/I4387153459"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"E. Biesheuvel","raw_affiliation_strings":["3Global Clinical Operations, Viatris Inc, Amstelveen, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Global Clinical Operations, Viatris Inc, Amstelveen, Netherlands","institution_ids":["https://openalex.org/I4387153459"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5093582047","display_name":"Pradeep Purushottamahanti","orcid":"https://orcid.org/0009-0000-8001-1305","observed_orcids":["https://orcid.org/0009-0000-8001-1305"]},"institutions":[{"id":"https://openalex.org/I4387153459","display_name":"Viatris","ror":"https://ror.org/01g1gvr46","country_code":"US","type":"company","lineage":["https://openalex.org/I4387153459"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"P. Purushottamahanti","raw_affiliation_strings":["4Global Medical Affairs, Viatris Inc, Bangalore, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Global Medical Affairs, Viatris Inc, Bangalore, India","institution_ids":["https://openalex.org/I4387153459"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5093582047"],"corresponding_institution_ids":["https://openalex.org/I4387153459"],"apc_list":{"value":3150,"currency":"USD","value_usd":3150},"apc_paid":{"value":3150,"currency":"USD","value_usd":3150},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"67","issue":"S1","first_page":"S535","last_page":"S536"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.8945000171661377,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.8945000171661377,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10786","display_name":"Maternal Mental Health During Pregnancy and Postpartum","score":0.10279999673366547,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10853","display_name":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/3205","display_name":"Experimental and Cognitive Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/major-depressive-disorder","display_name":"major depressive disorder","score":0.9940000176429749},{"id":"https://openalex.org/keywords/sertraline","display_name":"sertraline","score":0.9940000176429749},{"id":"https://openalex.org/keywords/women-of-reproductive-age","display_name":"women of reproductive age","score":0.9639999866485596},{"id":"https://openalex.org/keywords/selective-serotonin-reuptake-inhibitors","display_name":"selective serotonin reuptake inhibitors","score":0.8330000042915344},{"id":"https://openalex.org/keywords/pregnancy","display_name":"pregnancy","score":0.4099999964237213},{"id":"https://openalex.org/keywords/breastfeeding","display_name":"breastfeeding","score":0.8679999709129333},{"id":"https://openalex.org/keywords/sex-steroids","display_name":"sex steroids","score":0.5230000019073486},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.7580000162124634},{"id":"https://openalex.org/keywords/antidepressant-efficacy","display_name":"antidepressant efficacy","score":0.6610000133514404},{"id":"https://openalex.org/keywords/pooled-analysis","display_name":"pooled analysis","score":0.5139999985694885},{"id":"https://openalex.org/keywords/post-hoc-analysis","display_name":"post hoc analysis","score":0.47699999809265137},{"id":"https://openalex.org/keywords/women-s-mental-health","display_name":"women's mental health","score":0.48899999260902405},{"id":"https://openalex.org/keywords/maternal-mental-health","display_name":"maternal mental health","score":0.4740000069141388},{"id":"https://openalex.org/keywords/childbearing-age-women","display_name":"childbearing age women","score":0.5090000033378601},{"id":"https://openalex.org/keywords/antidepressant-safety","display_name":"antidepressant safety","score":0.3089999854564667}],"concepts":[{"id":"https://openalex.org/C2777669559","wikidata":"https://www.wikidata.org/wiki/Q407617","display_name":"Sertraline","level":4,"score":0.9263967871665955},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.5437745451927185},{"id":"https://openalex.org/C2780051608","wikidata":"https://www.wikidata.org/wiki/Q42844","display_name":"Major depressive disorder","level":3,"score":0.509512722492218},{"id":"https://openalex.org/C3019858935","wikidata":"https://www.wikidata.org/wiki/Q4340209","display_name":"Depressive symptoms","level":3,"score":0.5038120150566101},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.49929213523864746},{"id":"https://openalex.org/C70410870","wikidata":"https://www.wikidata.org/wiki/Q199906","display_name":"Clinical psychology","level":1,"score":0.4343389868736267},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3933267593383789},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.08142244815826416},{"id":"https://openalex.org/C169900460","wikidata":"https://www.wikidata.org/wiki/Q2200417","display_name":"Cognition","level":2,"score":0.04434001445770264},{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.0}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1192/j.eurpsy.2024.1111","doi":"https://doi.org/10.1192/j.eurpsy.2024.1111","is_oa":true,"landing_page_url":"https://doi.org/10.1192/j.eurpsy.2024.1111","pdf_url":"https://www.cambridge.org/core/services/aop-cambridge-core/content/view/841DDB24C4B809AC1ECE8192F854D190/S0924933824011118a.pdf/div-class-title-the-preponderance-of-major-depressive-disorder-among-women-of-reproductive-age-and-the-clinical-utility-of-sertraline-div.pdf","source":{"id":"https://openalex.org/S87202501","display_name":"European Psychiatry","issn_l":"0924-9338","issn":["0924-9338","1778-3585"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311721","host_organization_name":"Cambridge University Press","host_organization_lineage":["https://openalex.org/P4310311721","https://openalex.org/P4310311702"],"host_organization_lineage_names":["Cambridge University Press","University of Cambridge"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Psychiatry","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:11863073","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/11863073","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC11863073/pdf/S0924933824011118a.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Eur Psychiatry","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:b602ceb85dc74d07855c8dbf21a181ec","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/b602ceb85dc74d07855c8dbf21a181ec","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"European Psychiatry, Vol 67, Pp S535-S536 (2024)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1192/j.eurpsy.2024.1111","doi":"https://doi.org/10.1192/j.eurpsy.2024.1111","is_oa":true,"landing_page_url":"https://doi.org/10.1192/j.eurpsy.2024.1111","pdf_url":"https://www.cambridge.org/core/services/aop-cambridge-core/content/view/841DDB24C4B809AC1ECE8192F854D190/S0924933824011118a.pdf/div-class-title-the-preponderance-of-major-depressive-disorder-among-women-of-reproductive-age-and-the-clinical-utility-of-sertraline-div.pdf","source":{"id":"https://openalex.org/S87202501","display_name":"European Psychiatry","issn_l":"0924-9338","issn":["0924-9338","1778-3585"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311721","host_organization_name":"Cambridge University Press","host_organization_lineage":["https://openalex.org/P4310311721","https://openalex.org/P4310311702"],"host_organization_lineage_names":["Cambridge University Press","University of Cambridge"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Psychiatry","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4401919503.pdf","grobid_xml":"https://content.openalex.org/works/W4401919503.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4404141179","https://openalex.org/W2005378805","https://openalex.org/W4295241353","https://openalex.org/W2149959738","https://openalex.org/W4407118008","https://openalex.org/W4387905447","https://openalex.org/W7212070415","https://openalex.org/W2085358740","https://openalex.org/W2127113012","https://openalex.org/W7212001396"],"abstract_inverted_index":{"Introduction":[0],"Major":[1],"depressive":[2],"disorder":[3],"(MDD)":[4],"is":[5,14,119,436],"twice":[6],"as":[7],"common":[8],"in":[9,58,173,198,303,377,425,430,438,445],"women":[10,37,59,133,157,174,182,294,355,440],"than":[11,312,386],"men":[12],"and":[13,38,43,53,96,100,208,228,269,343],"more":[15],"frequently":[16],"reported":[17],"during":[18],"their":[19],"reproductive":[20,184],"years":[21],"(Shi":[22],"et":[23,61,103,135],"al.":[24,62,104,136],"Front.":[25],"Psychiatr":[26],"2021;":[27],"12":[28],"589687).":[29],"MDD":[30,57,155,201,219],"affects":[31],"up":[32],"to":[33,129,217,244,264,271,283],"12.7%":[34],"of":[35,56,117,121,149,154,158,171,183,191,196,210,248,292,318,356,360,392,450],"pregnant":[36],"can":[39,90,126],"significantly":[40,308,382],"impact":[41,91],"foetal":[42],"maternal":[44],"health.":[45],"Hence,":[46],"clinical":[47,194,371],"practice":[48],"guidelines":[49],"recommend":[50],"focused":[51],"screening":[52],"expedited":[54],"management":[55],"(Guo":[60],"Obstet.":[63],"Gynecol":[64],"2018;":[65,141],"131(4)":[66],"671-679).":[67],"Despite":[68],"this,":[69],"drug":[70,92],"labelling":[71],"or":[72,79,131],"dosing":[73],"recommendations":[74],"rarely":[75],"account":[76],"for":[77,114,151,226,231,310,313,354,384,387],"gender":[78],"physiological":[80],"differences":[81],"between":[82],"sexes,":[83],"even":[84],"though":[85],"sex":[86],"steroid":[87],"level":[88],"variations":[89],"absorption,":[93],"distribution,":[94],"metabolism,":[95],"activity":[97],"both":[98],"pharmacokinetically":[99],"pharmacodynamically":[101],"(Soldin":[102],"Clin":[105],"Pharmacokinet.":[106],"2009;":[107],"48(3):":[108],"143\u2013157).":[109],"Sertraline,":[110],"an":[111],"SSRI":[112],"approved":[113],"the":[115,122,147,152,169,246,273,316,390,431,446],"treatment":[116,153],"MDD,":[118,176,442],"one":[120],"safer":[123],"agents":[124],"which":[125],"be":[127],"given":[128],"childbearing":[130,159,447],"breastfeeding":[132],"(Cuomo":[134],"Expert":[137],"Opin":[138],"Drug":[139],"Saf":[140],"17(7)":[142],"719-725).":[143],"However,":[144],"studies":[145,195],"on":[146,181],"efficacy":[148,170,247],"sertraline":[150,172,197,227,233,249,311,385,435],"among":[156],"age":[160,358],"are":[161],"limited.":[162],"Objectives":[163],"This":[164,332,406],"post-hoc":[165],"pooled":[166,188],"analysis":[167,190,289,352],"evaluated":[168],"with":[175,177,200,215,251,280,441],"a":[178],"particular":[179],"focus":[180],"age.":[185,448],"Methods":[186],"A":[187],"data":[189],"8":[192,257,279,319,393],"short-term":[193],"persons":[199],"(comprising":[202],"1600":[203],"participants":[204,362],"from":[205,275,301,334,340,369,375,408,414],"North":[206],"America":[207],"Europe,":[209],"whom":[211],"947":[212,293],"were":[213],"females;":[214],"moderate":[216],"severe":[218],"[mean\u00b1SD":[220],"baseline":[221,276,302,335,376,409],"HAM-D17":[222,239,304,378,426],"score":[223,241,306,380],"was":[224,237,242,256,262,307,336,381,410,428],"23.73\u00b13.58":[225],"23.37\u00b1":[229],"3.47":[230],"placebo];":[232],"dose,":[234],"50-200":[235],"mg)":[236],"performed.":[238],"total":[240,305,379],"used":[243,263],"assess":[245],"compared":[250],"placebo.":[252],"The":[253,288,299,351,373],"study":[254],"period":[255],"weeks.":[258],"An":[259],"MMRM":[260],"method":[261],"analyse":[265],"changes":[266],"over":[267,345],"time":[268,346],"ANCOVA":[270],"evaluate":[272],"change":[274,300,333,374,407],"at":[277,315,389],"week":[278,341,415],"LOCF":[281],"employed":[282],"manage":[284],"missing":[285],"data.":[286],"Results":[287],"set":[290,353],"consisted":[291,359],"(sertraline,":[295,365],"612;":[296],"placebo,":[297,367],"335).":[298],"higher":[309,383],"placebo":[314,388],"end":[317,391],"weeks":[320,394],"(LS":[321,395],"mean":[322,396],"difference,":[323,397],"95%":[324,398],"CI:":[325,399],"-1.81":[326],"[-3.01,":[327],"-0.62],":[328],"p=0.0029,":[329],"Figure":[330,349,404],"1A).":[331],"statistically":[337,411],"significant":[338,412],"starting":[339,413],"2":[342,416],"increased":[344],"(Week":[347],"2-8;":[348],"2A).":[350],"child-bearing":[357],"572":[361],"aged":[363],"18-44":[364],"359;":[366],"213)":[368],"7":[370],"studies.":[372],"-2.08":[400],"[-3.52,":[401],"-0.64],":[402],"p=0.0047,":[403],"1B).":[405],"(Figure":[417],"2B).":[418],"Image:":[419],"Image":[420],"2:":[421],"Conclusions":[422],"Significant":[423],"improvement":[424],"scores":[427],"observed":[429],"analysis,":[432],"suggesting":[433],"that":[434],"efficacious":[437],"treating":[439],"including":[443],"those":[444],"Disclosure":[449],"Interest":[451],"A.":[452],"Fagiolini":[453],"Grant":[454],"/":[455],"Research":[456],"support":[457],"from:":[458],"Angelini,":[459,465,483],"Boheringer":[460,467,486],"Ingelheim,":[461,468,487],"Janssen,":[462,470,492],"Consultant":[463,505],"of:":[464,482,506,515,534,541],"Biogen,":[466,485],"Lundbeck,":[469,491],"Mylan,":[471,493],"Neuraxpharm,":[472,494],"Otsuka,":[473,495],"Pfizer,":[474,496],"Recordati,":[475,497],"Rovi,":[476,498],"Sanofi":[477,499],"Aventis,":[478,500],"Viatris,":[479,501],"Speakers":[480,513],"bureau":[481,514],"Apsen,":[484],"Glaxo":[488],"Smith":[489],"Kline,":[490],"Vifor,":[502],"M.":[503],"Mariano":[504],"Johnson":[507,526,528],"&":[508,527],"Johnson,":[509],"Otsuka":[510,519],"Pharmaceutical":[511],"Inc.,":[512,530],"Viatris":[516,535,542],"Pharmaceuticals,":[517],"Inc.":[518,522,536,543],"(Philippines)":[520],"Pharmaceutical,":[521],"H.":[523],"Lundbeck":[524],"A/S,":[525],"Philippines,":[529],"E.":[531],"Biesheuvel":[532],"Employee":[533,540],"Netherlands,":[537],"P.":[538],"Purushottamahanti":[539],"India":[544]},"counts_by_year":[],"updated_date":"2026-11-11T12:16:26.678958","created_date":"2024-08-28T00:00:00"}